Allurion relaunches weight loss balloon in France
February 13, 2025
Allurion Technologies (NYSE:ALUR) today announced the relaunch of its Allurion Balloon in France following regulatory clearance to resume sales.
Allurion Technologies (NYSE:ALUR) today announced the relaunch of its Allurion Balloon in France following regulatory clearance to resume sales.
With FDA clearance of SubtleHD™, Subtle Medical launches Subtle-ELITE™, an industry-first AI package designed to achieve superior image quality, unprecedented speed, and workflow automation
Professor Seunghyup Yoo’s research team in the Department of Electrical and Electronic Engineering developed the low-power, high-speed wearable CO2 sensor capable of stable breathing monitoring in real time.
A team led by University of Pittsburgh School of Public Health geneticists has shown, for the first time, that a gene “silencer” that resides in junk DNA is directly sparing people from a devastating and fatal progressive neurological disease.
VADUZ, Liechtenstein, Feb. 12, 2025 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, is pleased to announce that the FDA has accepted Module 1 of the company’s premarket approval (PMA) application, and that this module is now considered closed.
Johnson & Johnson MedTech (NYSE: JNJ)+
announced today that it launched the CereGlide 92 catheter system for treating acute ischemic stroke.
Sinocare announced recently that it successfully defended itself in court against trademark infringement claims brought by Abbott (NYSE:ABT).
The company announces CE MDR approval for its novel Delphi-MD neurodiagnosis medical device in preparation for EU commercialization, improving patients’ clinical outcomes and well being while reducing healthcare systems and payors’ financial burden.
A team of UC Berkeley engineers from the Embodied Dexterity Group has developed a wearable device to enhance grasping functionality in this population. Dubbed the Dorsal Grasper, this assistive device leverages voluntary wrist extension and uses supernumerary robotic fingers on the back of the hand to facilitate human-robot collaborative grasping.
Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have invented an oral formulation of arsenic trioxide (Oral-ATO; ARSENOL) for the treatment of acute promyelocytic leukemia (APL), a blood cancer that once had a high fatality rate.